Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Laboratory Evaluation of Acute Rejection, Myocyte Growth, Repair, and Oxidative Stress Following de Novo Cardiac Transplant: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens With MPA TDM

NCT00157014 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00157014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00157014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Laboratory Evaluation of Acute Rejection, Myocyte Growth, Repair, and Oxidative Stress Following de Novo Cardiac Transplant: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens With MPA TDM
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
May 10, 2004
Completion date
July 18, 2008
Enrollment
111 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

heart diseases, heart transplantation